All posts by EPR Network

Apparel & Fashion, Internet & Online, Retail, Shopping

Compact Footwear Category Showing Huge Growth as Footzyrolls Surpasses $1M mark after only one year in business, New Boho Summer Line is a Best Seller

Leave a comment

NEW YORK – Footzyrolls, the rollable shoe, the leader in the compact Footwear market with over $1M in Sales their first year, has leaped into fashion with their new collection, Bohemian Chic.

Debuting May 10, 2011, it has made a trend setting impact on compact flats. As Footzyroll’s summer collection, it features vibrant tie-dye colors, as well as chic corals and denim with flower piping in different styles. The collection showcases the classic Mary Jane style shoe with a striking look that is perfect for walking around the city or the shore during those hot summer days.

Footzyrolls are transforming comfort and style, and women have come to rely on these stylish flats to provide relief after a long day at work, summer travel, running around with the kids, or a night out on the town. The new Bohemian Chic shoe line embraces the “free spirited” iconic woman of any age. The Bohemian Chic collection will be available at high end boutiques across the country and at www.footzyrolls.com.

Footzyrolls’ innovative design allows them to be rolled up and fit practically everywhere: from the glove compartment in your car, to a tiny evening bag, Footzyrolls are conducive to providing instant relief for your aching feet! The trend for compact footwear was started by Footzyrolls, and this new collection elevates the fashion aspect of this functional flat. Every woman will eventually have at least one pair for every handbag!

Photos of the new collection can be viewed at http://bit.ly/mumpgA and this amazing and vibrant collection is priced from $25 to $30.

Celebrities who have gotten their hands (and feet) on Footzyrolls include: Beyonce, Blake Lively, Brittany Snow, Catherine Zeta Jones, Christina Ricci, Cynthia Nixon, Kendra Wilkinson, Kim Kardashian, Kristen Bell, Molly Ringwald, Rachel Bilson, Rachel Weisz, Rashida Jones, Rihanna, Susan Sarandon, Tinsley Mortimer, Whitney Port and up and coming singer Matisse.

Footzyrolls and the Footzyrolls Luxe Collections are currently sold in major department stores such as Bloomingdales, Macys and Lord & Taylor, as well as over 2,500 other retail stores. Additionally, they recently infiltrated the Las Vegas luxury market, and are now offered at hotels such as the Aria, Bellagio, Luxor, Mandalay Bay, Mirage, MGM, and the New York, New York. Footzyrolls is a registered Trademark of Rollashoe, LLC. Rollashoe, LLC is the creator of the Footzyrolls rollable shoe and Footzyroll flip-flops. Rollashoe is the world leader in the compact footwear accessories market and strives to make women’s lives fashionable yet functional. The company focuses on the ever changing needs of women.

Contact Details: Jenifer Caplan
1688 Meridian Ave Suite 418
Miami Beach, FL 33139
646-827-0673786-693-8978

Apparel & Fashion, Art, Retail, Shopping

Emporio Armani S/S 2011 Collection Available at TheWatchHut.co.uk

Leave a comment

May 10, 2011 /RTPR/– Make sure you spend your time stylishly this summer with a watch from the new Emporio Armani Spring/Summer 2011 collection, available now at the Watch Hut.

New Emporio Armani watches are just waiting to give your wrist a style overhaul, over at the UK’s largest watch website.

Famed for its sexy and youthful appeal, Giorgio Armani’s Emporio Armani brand is one of the most recognised fashion labels on the worldwide market today. Its clothing and accessories output is trendy, smart and cool – and its watches are no exception.

This season’s brand new Emporio Armani watches don’t fix what isn’t broken, providing the brand’s fashion-conscious followers with an extensive choice of sexy, sophisticated designer timepieces that complement the existing collection.

Key trends include the continuing popularity of black and white ceramic models, sporty yet smart chronograph bracelet watches, and contemporary takes on classic leather strap dress watches.

All-new Emporio Armani watches can be viewed on the Watch Hut’s dedicated brand section or within the ‘Latest New Models’ category.

The UK’s largest watch website is home to some of the world’s leading designer watch brands, including another hot Armani off-shoot, Armani Exchange. With over 6000 watches available from more than 60 popular watch brands, the Watch Hut is a one-stop destination for the best in wrist style.

To view Emporio Armani watches, visit the Watch Hut at http://www.thewatchhut.co.uk.

For further information, please contact Luke McNaney at luke.mcnaney@thbaker-watches.co.uk or on 01384 467592.

Company: The Watch Hut
Website: http://www.thewatchhut.co.uk Street address: 95 High Street, Brierley Hill, West Midlands

###

Biotech, Business, Financial, Healthcare, Religion, Science, Society

Advanced Cell Technology has pioneered a solution to the ethical, moral & legal debate raging in regards to protection of a human embryo

Leave a comment

May 10, 2011 /RTPR/– Advanced Cell Technology with laboratory facilities in Marlborough Massachusetts has pioneered a solution to the ethical, moral & legal debate raging in regards to protection of a human embryo. ACT has developed the “single-blastomere” technique. Patent Number 7,893,315 a non-destructive alternative for deriving human embryonic stem cell (hESC) lines.

This achievement in Regenerative medicine is a ground breaking feat for both Catholic and U.S. law.

• The 1995 encyclical The Gospel of Life, of which Pope John Paul II wrote: “Human embryos obtained in vitro are human beings and are subjects with rights; their dignity and right to life must be respected from the first moment of their existence. It is immoral to produce human embryos destined to be exploited as disposable ‘biological material'” (1,5 )
• The Dickey Amendment (also known as the Dickey-Wicker Amendment) is the name of an appropriation bill rider attached to a bill passed by United States Congress in 1995, and signed by former President Bill Clinton, which prohibits the Department of Health and Human Services (HHS) from using appropriated funds for the creation of human embryos for research purposes or for research in which human embryos are destroyed.

The single-blastomere technology uses a one-cell biopsy approach similar to pre-implantation genetic diagnosis (PGD), which is widely used in the in vitro fertilization (IVF) process and does not interfere with the embryo’s developmental potential. The stem cells generated using this approach are healthy, completely normal, and differentiate into all the cell types of the human The safety record for one-cell biopsy as part of PGD now has a 15-year track record, and is carried out routinely as part of IVF processes around the world. ACT’s technique of protecting the human embryo from harm can be expounded to the smallest blood transfusion in the world. As does a human being give millions of blood cells in a pint of blood so does ACT’s “single blastomere” process take but “one cell” from a 2 day old embryo. As the blood removed from a human donor “regenerate” the removed pint of blood so does the human embryo “regenerate” the one cell. Both of these procedures leave the human body & two day old embryo healthy. Both procedures are similar in that they both provide life saving material to those whom need them most to due to disease and other aliments of a medical nature.

Advanced Cell Technology has been granted by the US Food and Drug Administration (FDA) a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells for both Stargardt’s Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world and Dry Age-Related Macular Degeneration (AMD) the most common form of macular degeneration in the world affecting an estimated 150 million people. ACT is using RPE cells developed from the patented (SCB) technique for this trial. The trial will take place at UCLA’s Jules Stein Eye Institute in California. Because of the biological nature of the human eye the trial will be able to provide a 100% irrefutable proof that the (hESC) derived RPE cells used attached to the Bruch’s membrane. Before and after state of the art imaging will take place.

Raymond Lund, Ph.D., a scientific collaborator with ACT, and considered one of the world’s foremost experts in retinal cell physiology and vision restoration, commented, “The study results of ACT’s RPE cells implanted in the various animal models of macular degeneration was phenomenal. If ACT observes even a fraction of that benefit in humans, it will be nothing short of a home run.”

FDA validation will occur for (hESC) medicine in less than 12 months. Will those that dictate law and morality to others lead? Will those suffering from disease all over the world finally have conclusive proof that (hESC) work? Life is filled with multifaceted choices and in a rare occurrence a quantum leap shows itself to the world. Human flight, computers and now regenerative medicine.

Disclosure: Stem Cell Media LLC nor its Companies was compensated by “any” entity for this article.www.investorstemcell.com is bringing investors and stakeholders together to participate in the world’s only online discussion forum dedicated to regenerative medicine.

Contact Details: icell@investorstemcell.com
www.investorstemcell.com

###

Biotech, Business, Financial, Healthcare, Pharmaceuticals, Science

NASDAQ:GERN & OTC:ACTC – A David & Goliath Comparison

Leave a comment

May 09, 2011 /RTPR/– Regenerative medicine is a highly complicated and vastly misunderstood science. Investor Stem Cell is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible advancements unfolding in the regenerative medicine sector. A quantum leap in health care is upon the world. Will you profit from this emerging sector & help bring cures to millions? Find out now what the street thinks at www.investorstemcell.com.

Side by side comparison of Advanced Cell Technology & Geron Corporation:

Geron Corporation (NASDAQ:GERN), Approved by the FDA to use human embryonic stem cell (hESC) treatments to treat spinal cord injuries. The research Goliath is a well-funded machine employing the top minds in the world working on everything from mid-stage oncology trials to promising (hESC) drugs for spinal cord injuries, heart disease & cancer.

Snap shot of Goliath: Geron Corpoartion-(NASDAQ:GERN)-
• Seven oncology Phase 2 trials currently underway, and has several big Pharma joint venture agreements in oncology animal and human trials
• Five hESC areas of investigation underway. GRNOPC1 is the lead candidate. Geron destroys the human embryo through its (hESC) R&D, of which the company uses the blastocyst embryo formation at day five after fertilization from IVF clinics
• Cash, restricted cash, cash equivalents and marketable securities: $221,274.000.00
• Total operating expenses in 2010: $114,730,000.00
• 175 employees; over 100 hold PhD or MD degrees
• Geron Corporation was founded in 1990 and is based in Menlo Park, California
• Trades on the NASDAQ providing liquidity & large institutional investors
• Corporate financial statements:http://www.geron.com/investors/reports/GeronAnnualReport2010.pdf

Advanced Cell Technology not too long ago was the predominant leader in the field of regenerative medicine. It fell from that distinction in part due to executive management hubris and ultimately the credit crisis in mid-2008. ACT was able to resurrect itself from near bankruptcy in June 2008 and now has the distinction of holding two out of the three FDA approved (hESC) trials. ACT is led by a competent executive management team and employs several of the most predominant regenerative researcher(s) in the world.

Snap shot of David: Advanced Cell Technology-(OTC:ACTC)-
• Retinal Pigment Epithelial Cell Program is their lead program-(HESC) trials for both SMD/AMD are expected to start in week(s) Jules Stein Eye Institute at the University of California, Los Angeles (UCLA ) will conduct the 2 (hESC) trials for Stargardt’s Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (AMD)
• Filed a European Clinical Trial Application for Phase 1/2 study using (hESC) to treat macular degeneration
• Issued a broad patent for hESC-derived RPE cells in China
• Seeking funding & joint venture partner for Myoblast program for the treatment of cardiovascular disease Phase 2 approved by the FDA
• Joint ventured with Korean medical giant CHA to form “Stem Cell & Regenerative Medicine International” (SCRMI). This partnership expected to file an investigational new drug application (IND) with the FDA in Q-4 of this year. CHA biotech is waiting for final approval from the Korea Food and Drug Administration for (hESC) trial for AMD
• Issued patent on its “single-blastomere” technique. Patent Number 7,893,315 broadly covers ACT’s proprietary single-blastomere technology that provides a non-destructive alternative for deriving hESC lines. This “Embryo-Safe” one-cell biopsy approach similar to pre-implantation genetic diagnosis (PGD), which is widely used in the in vitro fertilization (IVF) process and does not interfere with the embryo’s developmental potential
• 22 full-time employees, six hold PhD or MD degrees-Formed in 1994, HQ in Menlo Park, California with laboratory facilities in Marlborough, MA
• Total operating expenses in 2010: $22,044,701
• Cash, restricted cash, cash equivalents and marketable securities: $34,889,409
• Trades on the OTC:BB ACTC is a Sarbanes–Oxley Act SEC reporter
• Corporate financial statements:http://www.sec.gov/Archives/edgar/data/1140098/000101376211000631/form10k.htm

If you are looking for maximum possible ROI in the short term and can tolerate high risk, then maybe Advanced Cell Technology (OTC:ACTC) is for you? If ACT is validated by the FDA, the (RPE) MA-09 “embryo-safe” cell lines would open up an annual $25,000,000,000.00 market treating (AMD). Yes that is (b) with an (illion) annual market share! No FDA approved treatment exist for (AMD) in the world. This disease effects 30 million in the USA & EU alone. Cell lines have potential to treat 200 retinal eye diseases. ACT has been approved for U.S. Orphan Drug status protection for (SMD). This status by the FDA provides ACT seven years of market protection. ACT is expecting EU-Orphan Drug status for (SMD) and if awarded would receive 10-years of market protection. The recent patent protection for ACT’s RPE cells in China firmly establish potential world dominance of the (AMD) market. What is the down side? One glaring red flag is that ACT has two years of operating capital and enough cash to fund both the SMD/AMD Phase-1/2 trials in the U.S. If ACT’s AMD/SMD trials are not validated, ACT would most likely be forced to institute a massive reverse split due to the O/S nearing its A/S. ACT has placed all of its eggs in one pipeline basket, choosing the low hanging fruit model. ACT is counting on the exceptional Casey Eye Clinic animal results. Dr. Raymond Lund Ph.D., considered one of the world’s foremost experts in retinal cell physiology and vision restoration. Dr. Lund recently said the following: “The study results of ACT’s RPE cells implanted in the various animal models of macular degeneration was phenomenal. If ACT observes even a fraction of that benefit in humans, it will be nothing short of a home run.”

Disclosure: www.investorstemcell.com is the world’s only online discussion forum dedicated bringing investors & stakeholders together in thoughtful discussion about stem cell & regenerative medicine. www.investorstemcell.com nor any of its Companies have been compensated by “any” party for this article. Before making an investment decision an investor should perform due diligences. Once completed find out what the street thinks at www.investorstemcell.com

Contact Details: www.investorstemcell.com
icell@investorstemcell.com

###

Automotive, Marketing, Transportation & Logistics

RPM Auto Sales USA Has Grown Into One Of The Largest Used Car And Truck Dealers In Ocean County

Leave a comment

May 07, 2011 /RTPR/ — RPM Auto Sales USA located at 980 Route 9 in Bayville has grown it’s business into one of the largest used car and truck dealers in Ocean County by exceeding their customer’s expectations. RPM only inventories the highest quality of used cars and trucks so that customers who visit the Rpm 6 acre facility want to buy their vehicles hence, there is never any pressure to buy from their friendly staff.

RPM Autos has used vehicle buyers that have over 100 years of used car experience that purchase clean vehicles for RPM’s customers with clean
Carfaxes. Rpm has finance reps on location to get all loans approved for their clients on the spot with rates as low as 3.9%. Please call Rpm Auto Sales Usa at 800.622.7079 for more info or visit their website at www.rpmautosalesusa.com.

RPM Auto Sales…Your Friends in The Business!

Contact Details: RPM Auto Sales Usa
980 RT 9
Bayville, NJ, 08721
800.622.7079 www.rpmautosalesusa.com

###

Accounting, Financial, Government, Internet & Online, Non-Profit, Society

New Report Describes Poor Quality Tax Preparation In New Mexico

Leave a comment

LONGMONT, Colorado (May 6, 2011) – Between February 1 and April 18, 2011, First Nations Development Institute conducted 12 “mystery shopper” tests of paid tax preparers in New Mexico. These mystery shopper tests were conducted in communities with a high Native American population and close to Indian reservations. First Nations visited tax preparer sites in Gallup, Grants, Bernalillo, Farmington, and Albuquerque, New Mexico. The goal of the work was to assess the quality of tax preparation services and to test the hypothesis that the tax preparation firms are steering people toward expensive products, such as Refund Anticipation Loans or Refund Anticipation Checks.

This research uncovered several problems with inaccurate, unethical, or unprofessional behavior on the part of tax preparers. “In our small sample of mystery shoppers, it was shocking what we uncovered,” stated Shawn Spruce, a financial education consultant for First Nations. Spruce also shared,“Unfortunately, the companies that our mystery shoppers visited did a poor job preparing even basic tax returns and could have exposed them to serious tax liability. In general, we were startled by the low quality service and the fact that two of these companies automatically signed our shoppers up for expensive Refund Anticipation Checks, even though they could have directly deposited their tax returns into their own bank accounts.”

Michael E. Roberts, president of First Nations Development Institute, stressed the importance of conducting the mystery shopper tests and resulting research on tax preparers.

“This research reinforces what other studies have found,” stated Roberts. “There is a great need for better regulation of tax preparers so that low-income people can hold on to their hard earned tax refunds and avoid expensive and predatory products like Refund Anticipation Checks. It is unfortunate that tax time serves as an opportunity to exploit Native American taxpayers through high fees and unnecessary products that take money out of taxpayers’ pockets.”

On May 4, 2011, Spruce presented the findings in Tax Time Troubles, a First Nations Development Institute report that provides details about predatory, unprofessional, and inaccurate tax preparation firms serving often low income communities in New Mexico. Spruce was the evening keynote speaker at the Effective Asset Building Strategies in New Mexico conference being held at the Indian Pueblo Cultural Center in Albuquerque, New Mexico. This conference was sponsored by Prosperity Works, a nonprofit organization that works to reduce the impact of predatory lending and whose mission is to ensure that every New Mexican has the opportunity, knowledge and relationships to achieve economic prosperity.

For more information about the research report Tax Time Troubles, visit First Nations Development Institute’s website at www.firstnations.org.

###

CONTACT:
Sarah Dewees, Senior Director of Research, Policy, and Asset-Building Programs
First Nations Development Institute
2217 Princess Anne Street, Suite 111-1
Fredericksburg, VA 22401
Tel/540.371.5615
Fax/888.371.3686
sdewees@firstnations.org

###

Consumer Services, Entertainment, Internet & Online, Kids & Teens, Media, Social Media, Society

BabyFirstTV.com Turns 5 Years This Mother’s Day

Leave a comment

LOS ANGELES (May 5, 2011) – Mother’s Day marks the 5 th birthday of BabyFirstTV, the global TV network designed for babies and parents. Since its launch in 2006, the network has grown to become a multi-platform media company with family-friendly content extending beyond the TV to mobile devices and the internet.

BabyFirstTV.com, the latest product stemming from the media company, is a colorful, interactive website that combines over 400 videos, games and activities all designed specifically for toddlers. Created by early childhood development experts, the website is commercial-free and full of fun ways for parents and children to interact together – online. Families around the world can use BabyFirstTV.com completely for free this Mother’s Day weekend, May 6-9.

“Our fifth anniversary, is a great opportunity to thank the millions of moms and dads around the globes, that have followed us, and have become part of the BabyFirst family,” said co-founder, Sharon Rechter.

“To celebrate the unique bond between children and their parents, we have made the BabyFirstTV.com subscription service free for parents and toddlers to play, explore and discover together.”

Outside the Mother’s Day free trial weekend, BabyFirstTV.com is available as a subscription-based service for $3.99 a month or an annual fee of $19.99 (which includes two free BabyFirstTV DVDs). Existing BabyFirstTV channel subscribers pay only $1.99 per month.

About BabyFirstTV:

BabyFirstTV is a commercial–free, 24/7 network for young children and their parents.  Working closely with an extensive network of renowned authorities in every area of early childhood psychology and education, BabyFirstTV is a trusted, age-appropriate network throughout the world. BabyFirstTV is currently available to more than 50 million households in 35 countries including the top five U.S. satellite and cable operators. BabyFirstTV is included in the basic package on Dish Network and available as a premium service via DIRECTV, Time-Warner, Comcast and Charter. BabyFirstTV is committed to creating a commercial-free, nurturing and interactive environment by offering an ever-changing lineup of quality content.  For more info: www.babyfirsttv.com.

###

Biotech, Financial, Healthcare, Pharmaceuticals, Science

Investor Stem Cell Launches Online Discussion Community Dedicated To Stem Cell Investors

Leave a comment

APR 29, 2011 /RTPR/ — Investor Stem Cell (http://www.investorstemcell.com) is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible medical advancements taking place in the regenerative medicine sector. Scientists are using stem cells both (hESC) and (iPSC) in hopes of easing the suffering of hundreds of millions of people world wide.

Our society is on the verge of a quantum leap moment in time thanks to regenerative medicine.

Regenerative medicine and Stem Cell research:

Utter those words at your next dinner party or casual gathering of friends and family. You will receive a concoction of half-truth’s and out right fallacy responses. Stem Cell research conjures images of futuristic Star–Trek like preservation chambers, human looking ears protruding oddly from the backs of mice, or worse yet an image of a late term fetus. Nothing could be farther from the truth when entering the reality of Regenerative medicine.

Never before has this area of research been more exciting and promising than right now. There is a medical revolution brewing, and like any revolution, there are those who want to suppress this uprising for continued personal and ideological gains. If we were to take all the major advances in the past 500 years of human medical history and multiply its effect by 10 fold it still would not compare to the paradigm shift in health care delivery that the world may witness in this decade using stem cells. Imagine that an $800,000 heart transplant is no longer needed and that instead the same money spent on one patient can now be stretched out to treat 20 patients who are needing a heart transplant. Is this what Regenerative medicine has in the offing? Only time will tell. Our healthcare system could very well be on the verge of a quantum leap moment thanks to regenerative medicine.

The Food and Drug Administration (FDA) authorized 3 trials using human embryonic stem cells (hESC) in late 2010. Validation of hESC research efforts and the culmination of billions spent on research are coming to fruition. FDA validation for the treatments of spinal cord injury and age related macular degeneration is expected in 2011. It may be the shot heard around the world event sometime in late Q-4 2011 for the Regenerative medicine sector.

Find out more at http://www.investorstemcell.com, where investing is much more than charts and numbers.

Investor Stem Cell offers dedicated forums to the following Stem Cell Companies.
Investor Stem Cell is free to all members and employs the state of the art discussion web based software to maximize the experience of its members and the user experience. Get involved now and start separating fact from fiction in Regeneration medicine.

Investor Stem Cell provides Forums for the below Stem Cell Companies.

Advanced Cell Technology (OTC:ACTC) Geron Corporation (NASDAQ:GERN)

Cord Blood America (Public, OTC:CBAI) BioTime (AMEX:BTX)

Aastrom Biosciences (NASDAQ:ASTM) Athersys Inc. (NASDAQ:ATHX)

International Stem Cell Corporation (OTC:ISCO) MultiCell (OTC:MCET)

StemCells, Inc. (NASDAQ:STEM) Thermogenesis (NASDAQ:KOOL)

Bioheart Inc. (OTC:BHRT) RTI Biologics (NASDAQ:RTIX)

Pluristem Therapeutics Inc. (NASDAQ:PSTI) Bio-Matrix Scientific Group (PINK:BMSN)

Neuralstem (AMEX:NBS) Opexa Therapeutics (NASDAQ:OPXA)

Stem Cell Authority (PINK:SCLL) Brainstorm Cell Therapeutics (OTC:BCLI)

Stem Cell Therapeuitics (CVE:SSS) Cyro-Cell International (OTC:CCEL)

CellCyte Genetics(OTC:CCYG) Stem Cell Innovations (PINK:SCLL)

BioMimetic Therapeutics (NASDAQ:BMTI) Mesoblast (ASX:MSB)

Cytori Therapeutics (NASDAQ:CYTX) SANUWAVE Health, Inc. (OTC:SNWV)

Disclosure: By being a visitor and or member of Investor Stem Cell you agree to adhere to the Terms of Service at all times & pay strict attention to (TOS) Stem Cell Media LLC – http://www.investorstemcell.com is not paid by any 3rd party now or in the future to promote “any” companies for credibility and ethical reasons. Investors Stem Cell is not a financial advisory service. Consult your financial advisor at all times before making an investment. Our society is on the verge of a quantum leap moment in time thanks to regenerative medicine.

Contact Details: www.investorstemcell.com
email = icell@investorstemcell.com

###

Art, Entertainment, Marketing, Media, Music

Chicago based artist Narisah Announces New Single Release

Leave a comment

Narisah jokes that she’s a German pop / Ghettotech artist because she says her music is art and belongs to no particular genre. Narisah a Chicago based artist is set to unveil her new single ‘Crash Dummy’ on April 29th, 2011.

The track comes from the forthcoming studio album ‘Crash Dummy’ which consequently has a revised release date of early July 2011. She’s working with her long time producer Ic.ON from Chicago on the project.

‘Crash Dummy’, which will be available in Digital format only, will be the first single released off of the Crash Dummy EP due out in early July of 2011. It follows previous singles ‘E.S.P’ the theme song from the movie E.S.P and ‘Money’ from the sound track of ‘E.S.P’ the movie.

‘Crash dummy’ the single will be available for a free download. The music video is approaching too.

‘Crash Dummy’ the EP will be released in early July 2011.

For more information and to download the new single visit:
http://www.reverbnation.com/narisah
www.myspace.com/NerissaRahKelly
http://www.narisah.com/

Contact Details: Shannon Lechner
707 E Mulberry #2
Chatham, IL815-302-1422

###

Art, Construction, Home & Garden, Marketing, Media, Real Estate, Retail, Shopping

Ligne Roset Sponsors the Wanted Design NYC

Leave a comment

APR 28, 2011 /RTPR/ — Ligne Roset is proud to announce its sponsorship of the Wanted Design NYC, a fresh and exciting addition to Design Week, held in New York City. This creative platform for international designers, architects, and manufacturers to discuss and share exciting, inspiring and innovative ideas will take place from May 13 through May 16.

Ligne Roset will be honored by the presence of Philippe Nigro, who will present some of his pieces introduced earlier this year at IMM and Maison et Objet.

Creations designed by Philippe Nigro include Inseparables and T.U., and some of the new pieces making their debut Stateside will be Passio, Cuts and Stripes. Inseparable is a multifunctional piece which can act as a sofa end table, seat or simply a foot rest. The table can be slotted into the footstool or kept separately. The T.U. table also demonstrates a versatile quality as it has reversible top panels which can be flipped to show different materials and colors or can be altered in terms of width and height to suit the room or occasion. The sofa Passio is the introduction to our new outdoor collection. Its inventive design was conceived for indoor living, but the choice of materials allows it to be enjoyed outdoors. Nigro’s signature themes of intersections and interlocking elements are apparent in the arms and back. His passion for repetition and variation continues with the bookcase Cuts and with the pendant lamp Stripes.

In conjunction with Wanted Design, Ligne Roset’s Soho showroom will decorate its window with Ploum, one of the most exciting pieces to come out of IMM Cologne 2011. Designed by Ronan & Erwan Bouroullec, this will mark the first time Ploum will be seen in North America.

Inga Sempé,

Ligne Roset is also proud to congratulate designer Inga Sempé, who was recently recognized at the 9 th Annual Elle Decoration International Design Awards (EDIDA). She won the Seating Category with her Ruché sofa and was also named Designer of the Year. This innovative sofa gets its name from the technique of gathering or pleating material and has a solid wood structure.

Ligne Roset

Ligne Roset is an international contemporary furnishings company with a high-end, design-forward line of upholstery, cabinetry, lighting, accessories and textiles geared toward the modern lifestyle. Recent introductions include artful collaborations with world’s most dynamic designers such as Inga Sempé, Ronan & Erwan Bouroullec and Philippe Nigro, as well as pieces by established talents such as Didier Gomez and Pascal Mourgue. For Wanted Design, Ligne Roset is excited to highlight pieces by renowned young designer Philippe Nigro.

For more information about Ligne Roset, please visit the website http://www.ligne-roset-usa.com or for readers in the UK please visit http://www.ligne-roset.co.uk/. If you’re interested in learning more about the event, please check out their website www.wanteddesignnyc.com.

###